Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Thoroughbred fracture risk linked to collagen, study finds
This lack of collagen type III is a result of a change in their DNA sequence.

Horses with lower levels of collagen type III are at higher risk.

Researchers from the Royal Veterinary College (RVC) have developed a new genetic risk scoring system, after discovering new factors contributing to thoroughbred horses’ likelihood of fracture .

Their research revealed that thoroughbred horses with lower levels of collagen type III were at higher risk of fractures.

RVC’s research team, led by Dr Debbie Guest, developed a polygenic risk scoring system to measure horses’ disease risk. The system considers a variety of genes to assess the risk, which the team then used to look at the distribution of scores across the UK’s thoroughbred population.

Using this data, the researchers then selected cells from horses at either end of the risk spectrum to study further.

The cells were examined in a laboratory, to establish a cell model and find new genetic factors that may be involved in fracture risk.

The studies revealed that the horses with a higher risk of fracture also had lower levels of collagen type III. Collagen type III is a gene, found in their bone cells, which is required for normal bone formation.

The researchers say that this lack of collagen type III is a result of a change in their DNA sequence, in the region controlling how much collagen III is produced.

Further research will seek to validate the risk-scoring system using another group of horses. Studies will also use this system and cell model to identify any other genes and processes which may contribute to fracture susceptibility.

Dr Guest, project lead and senior research fellow at the RVC, said: “The development of a polygenic risk score for fracture will allow us to identify horses that are at high genetic risk to allow the targeted use of diagnostic imaging and close monitoring of their bone health.

“This study has also demonstrated the power of using cell models to work out what differences exist in bone cells from high and low-risk horses and therefore why some horses are at high risk.

“This is vital to develop new interventions for high-risk horses in the future so that they are less likely to suffer from a catastrophic fracture."

The full study can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.